NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹4,327 Cr |
| Mar2024 | ₹3,051 Cr |
| Mar2023 | ₹2,317 Cr |
| Mar2022 | ₹1,776 Cr |
| Mar2021 | ₹1,819 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,327 Cr | 41.82 | |
| Mar2024 | ₹3,051 Cr | 31.65 | |
| Mar2023 | ₹2,317 Cr | 30.45 | |
| Mar2022 | ₹1,776 Cr | -2.36 | |
| Mar2021 | ₹1,819 Cr | - | |
Compare Net Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,079.6 Cr | -1.9% | -5.6% | -1.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.9% |
-5.6% |
-1.1% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses